ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 183 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 6.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $65,000 | -53.9% | 69,891 | +1.2% | 0.00% | – |
| Q4 2019 | $141,000 | -28.8% | 69,092 | 0.0% | 0.00% | – |
| Q3 2019 | $198,000 | -62.6% | 69,092 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $530,000 | -41.6% | 69,092 | +1.2% | 0.00% | -50.0% |
| Q1 2019 | $907,000 | -14.8% | 68,271 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,064,000 | -18.8% | 68,271 | +2.4% | 0.00% | -33.3% |
| Q3 2018 | $1,310,000 | -31.6% | 66,686 | -0.0% | 0.00% | -25.0% |
| Q2 2018 | $1,915,000 | +23.0% | 66,709 | +1.3% | 0.00% | +33.3% |
| Q1 2018 | $1,557,000 | +6.3% | 65,846 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $1,465,000 | -10.6% | 68,300 | -1.4% | 0.00% | -25.0% |
| Q3 2017 | $1,638,000 | +8.3% | 69,271 | -9.8% | 0.00% | +33.3% |
| Q2 2017 | $1,512,000 | -15.0% | 76,774 | -9.3% | 0.00% | -25.0% |
| Q1 2017 | $1,778,000 | +6.7% | 84,674 | -4.5% | 0.00% | +33.3% |
| Q4 2016 | $1,667,000 | -12.3% | 88,674 | -2.5% | 0.00% | -25.0% |
| Q3 2016 | $1,900,000 | -17.4% | 90,974 | +0.9% | 0.00% | -20.0% |
| Q2 2016 | $2,300,000 | -4.4% | 90,174 | -0.8% | 0.01% | 0.0% |
| Q1 2016 | $2,405,000 | -29.1% | 90,935 | +14.6% | 0.01% | -37.5% |
| Q4 2015 | $3,394,000 | +64.0% | 79,333 | +1.6% | 0.01% | +60.0% |
| Q3 2015 | $2,069,000 | -20.6% | 78,052 | -0.1% | 0.01% | -16.7% |
| Q2 2015 | $2,605,000 | +2.7% | 78,152 | +2.6% | 0.01% | 0.0% |
| Q1 2015 | $2,536,000 | -20.0% | 76,199 | -1.8% | 0.01% | -14.3% |
| Q4 2014 | $3,171,000 | +21.8% | 77,599 | +0.9% | 0.01% | +16.7% |
| Q3 2014 | $2,604,000 | +1.6% | 76,870 | +1.1% | 0.01% | 0.0% |
| Q2 2014 | $2,563,000 | -8.4% | 76,034 | +3.0% | 0.01% | -14.3% |
| Q1 2014 | $2,799,000 | +30.6% | 73,834 | +0.5% | 0.01% | +16.7% |
| Q4 2013 | $2,144,000 | -14.2% | 73,434 | +0.7% | 0.01% | -14.3% |
| Q3 2013 | $2,500,000 | +7.2% | 72,934 | +3.2% | 0.01% | -12.5% |
| Q2 2013 | $2,332,000 | +4.4% | 70,689 | +1.3% | 0.01% | +14.3% |
| Q1 2013 | $2,234,000 | – | 69,755 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 7,106,955 | $139,652,000 | 2.69% |
| Malaga Cove Capital, LLC | 52,987 | $1,035,000 | 0.56% |
| PFM Health Sciences, LP | 1,699,100 | $33,387,000 | 0.49% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 75,000 | $1,474,000 | 0.43% |
| Spark Investment Management LLC | 320,400 | $6,295,000 | 0.36% |
| PFM Health Sciences, LP | 1,247,434 | $24,512,000 | 0.36% |
| Partner Investment Management, L.P. | 20,900 | $411,000 | 0.32% |
| Kazazian Asset Management, LLC | 14,454 | $284,000 | 0.27% |
| DLD Asset Management, LP | 271,500 | $5,327,000 | 0.26% |
| Partner Investment Management, L.P. | 15,516 | $305,000 | 0.23% |